Search research articles
Contact Us
Filters
Showing results (271-280 of 516) with videos related to
Page
of 52
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
August 8, 2024
Comparison of Laboratory Data at Initial Diagnosis of Multiple Myeloma Between Black Africans, African Americans and White patients
Lambert A Essiaw, Abiola Bolarinwa, Hongwei Tang, et al.
Blood
|
May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
Anita D'Souza, Martha Lacy, Morie Gertz, et al.
Oncogene
|
June 9, 2005
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway
Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Cancer Medicine
|
June 22, 2018
ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
Chuan Wu, Ting Yang, Yingmin Liu, et al.
Mayo Clinic Proceedings
|
January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma
Shaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology
|
November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis
Maria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Blood
|
September 25, 2024
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
Rahul Banerjee, Rachael Sexton, Andrew J Cowan, et al.
American Journal of Hematology
|
August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma
Kristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
American Journal of Hematology
|
February 13, 2021
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy
Kitsada Wudhikarn, Leslie Padrnos, Terra Lasho, et al.
American Journal of Cancer Research
|
July 12, 2021
A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
Robert F Cornell, Michael R Bishop, Shaji Kumar, et al.
Page
of 52
Search research articles
Search
Showing results (271-280 of 516) with videos related to
Sort By:
Page
of 52
Clinical Lymphoma, Myeloma & Leukemia
|
August 8, 2024
Comparison of Laboratory Data at Initial Diagnosis of Multiple Myeloma Between Black Africans, African Americans and White patients
Lambert A Essiaw, Abiola Bolarinwa, Hongwei Tang, et al.
Blood
|
May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
Anita D'Souza, Martha Lacy, Morie Gertz, et al.
Oncogene
|
June 9, 2005
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway
Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Cancer Medicine
|
June 22, 2018
ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
Chuan Wu, Ting Yang, Yingmin Liu, et al.
Mayo Clinic Proceedings
|
January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma
Shaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology
|
November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis
Maria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Blood
|
September 25, 2024
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
Rahul Banerjee, Rachael Sexton, Andrew J Cowan, et al.
American Journal of Hematology
|
August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma
Kristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
American Journal of Hematology
|
February 13, 2021
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy
Kitsada Wudhikarn, Leslie Padrnos, Terra Lasho, et al.
American Journal of Cancer Research
|
July 12, 2021
A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
Robert F Cornell, Michael R Bishop, Shaji Kumar, et al.
Page
of 52